(Press-News.org) A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine.
The cholesterol receptor offers a promising new target for anti-viral therapy, for which an approved drug may already exist, say the researchers, whose findings were reported online in advance of publication in Nature Medicine.
An estimated 4.1 million Americans are infected with hepatitis C virus, or HCV, which attacks the liver and leads to inflammation, according to the National Institutes of Health. Most people have no symptoms initially and may not know they have the infection until liver damage shows up decades later during routine medical tests.
Previous studies showed that cholesterol was somehow involved in HCV infection. The UIC researchers suspected that a receptor called NPC1L1, known to help maintain cholesterol balance might also be transporting the virus into the cell.
The receptor is common in the gut of many species -- but is found on liver cells only in humans and chimpanzees, says Susan Uprichard, assistant professor in medicine and microbiology and immunology and principal investigator in the study. These primates, she said, are the only animals that can be infected by HCV.
Uprichard and her coworkers showed that knocking down or blocking access to the NPC1L1 receptor prevented the virus from entering and infecting cells.
Bruno Sainz, Jr., UIC postdoctoral research associate in medicine and first author of the paper, said because the receptor is involved in cholesterol metabolism it was already well-studied. A drug that "specifically and uniquely targets NPC1L1" already exists and is approved for use to lower cholesterol levels, he said.
The FDA-approved drug ezetimibe (sold under the trade-name Zetia) is readily available and perfectly targeted to the receptor, Sainz said, so the researchers had an ideal method for testing NPC1L1's involvement in HCV infection.
They used the drug to block the receptor before, during and after inoculation with the virus, in cell culture and in a small-animal model, to evaluate the receptor's role in infection and the drug's potential as an anti-hepatitis agent.
The researchers showed that ezetimibe inhibited HCV infection in cell culture and in mice transplanted with human liver cells. And, unlike any currently available drugs, ezetimibe was able to inhibit infection by all six types of HCV.
The study, Uprichard said, opens up a number of possibilities for therapeutics.
Hepatitis C is the leading cause for liver transplantation in the U.S., but infected patients have problems after transplant because the virus attacks the new liver, Uprichard said.
While current drugs are highly toxic and often cannot be tolerated by transplant patients taking immunosuppressant drugs, ezetimibe is quite safe and has been used long-term without harm by people to control their cholesterol, Uprichard said. Because it prevents entry of the virus into cells, ezetimibe may help protect the new liver from infection.
For patients with chronic hepatitis C, ezetimibe may be able to be used in combination with current drugs.
"We forsee future HCV therapy as a drug-cocktail approach, like that used against AIDS," Uprichard said. "Based on cell culture and mouse model data, we expect ezetimibe, an entry inhibitor, may have tremendous synergy with current anti-HCV drugs resulting in an improvement in the effectiveness of treatment."
INFORMATION:
The study was supported by NIH Public Health Service grants, the American Cancer Society Research Scholar grant, the UIC Center for Clinical and Translational Science NIH grant, the UIC Council to Support Gastrointestinal and Liver Disease, and a grant from the Ministry of Health, Labor and Welfare of Japan.
Naina Barretto, Danyelle Martin, Snawar Hussain, Katherine Marsh and Xuemei Yu, of UIC; Nobuhiko Hiraga, Michio Imamura and Kazuaki Chayama, of Hiroshima University in Japan; and Waddah Alrefai of UIC and the Jesse Brown VA Medical Center in Chicago also contributed to the study.
[Editor's Note: Images available at newsphoto.lib.uic.edu/v/uprichard/]
For more information about the University of Illinois Medical Center, visit www.uillinoismedcenter.org
END
RIVERSIDE, Calif. – In August 2010, an entomologist at the University of California, Riverside discovered a tiny fairyfly wasp in upstate New York that had never been seen in the United States until then. Nearly exactly a year later, he discovered the wasp in Irvine, Calif., strongly suggesting that the wasp is well established in the country.
Called Gonatocerus ater, the wasp is about 1 millimeter long and arrived in North America from Europe. It lays its eggs inside the eggs of leafhoppers.
Leafhopper females lay their eggs inside plant tissue. Gonatocerus ater ...
Hampton Inn Atlanta-Southlake Morrow GA Hotel offers affordable accommodations to participants and guests attending the Metropolitan Opera National Council auditions. Taking place at Clayton State University's Spivey Hall, the auditions will be held on Sunday, February 5, 2012. At the event, outstanding young vocalists from North Carolina, South Carolina, Florida, and Georgia will sing opera arias before a panel of expert judges, competing to advance to the national finals on stage at the Metropolitan Opera in New York. Tickets are $35 and can be purchased through Spivey ...
Sheraton Atlanta Perimeter North / Dunwoody Hotel, located at Atlanta Perimeter Center, announces a new special savings package for travelers to enjoy. Guests who register for the SPG Better by the Night promotion can earn unlimited bonus Starpoints even faster. With every stay from January 9 through April 8, 2012, at this property and over 750 other participating hotels and resorts worldwide, guests earn double Starpoints on two-night stays and triple Starpoints on stays of three nights or longer.
Register by March 15, 2012, and then book your stays to begin earning ...
Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease. The study showed a close association with two conditions in particular: high blood pressure and elevated fasting blood sugar levels, which is a precursor to diabetes. The research is published today in the medical research journal Translational Psychiatry.
"This is the first report of an underlying ...
RIVERSIDE, Calif. – A research team led by physicists at the University of California, Riverside has identified a property of "bilayer graphene" (BLG) that the researchers say is analogous to finding the Higgs boson in particle physics.
Graphene, nature's thinnest elastic material, is a one-atom thick sheet of carbon atoms arranged in a hexagonal lattice. Because of graphene's planar and chicken wire-like structure, sheets of it lend themselves well to stacking.
BLG is formed when two graphene sheets are stacked in a special manner. Like graphene, BLG has high current-carrying ...
COLUMBUS, Ohio – On any given weekend, at least 10 percent of students at a single college could be hosting a party, and on average, party hosts who live off campus are drinking more and engaging in more alcohol-related problem behaviors than are the students attending their bashes, research suggests.
In contrast, hosts of parties held on campus tend to drink less than do the students attending their gatherings, according to the study.
The research also suggests that college party hosts are more likely than the students attending parties to be male, living off campus, ...
Santa Barbara, CA –The Bren School-based authors of a study published Jan. 20 in the journal PLoS ONE have observed toxicity to marine organisms resulting from exposure to a nanoparticle that had not previously been shown to be toxic under similar conditions.
Lead author and assistant research biologist Robert Miller and co-authors Arturo Keller and Hunter Lenihan – both Bren School professors and lead scientists at the UC Center for Environmental Implications of Nanotechnology (UC CEIN) – Bren Phd student Samuel Bennett, and Scott Pease, a former UCSB undergraduate ...
The fate of the world's great whale species commands global attention as a result of heated debate between pro and anti-whaling advocates, but the fate of smaller marine mammals is less understood, specifically because the deliberate and accidental catching and killing of dolphins, porpoises, manatees, and other warm-blooded aquatic species are rarely studied or monitored.
To shed more light on the issue, researchers from the Wildlife Conservation Society and Okapi Wildlife Associates have conducted an exhaustive global study of human consumption of marine mammals using ...
HOUSTON -- Rice University physicists have gone to extremes to prove that Isaac Newton's classical laws of motion can apply in the atomic world: They've built an accurate model of part of the solar system inside a single atom of potassium.
In a new paper published this week in Physical Review Letters, Rice's team and collaborators at the Oak Ridge National Laboratory and the Vienna University of Technology showed they could cause an electron in an atom to orbit the nucleus in precisely the same way that Jupiter's Trojan asteroids orbit the sun.
The findings uphold a ...
When it comes to conserving the world's orchids, not all forests are equal. In a paper to be published Jan. 25 in the journal Molecular Ecology, Smithsonian ecologists revealed that an orchid's fate hinges on two factors: a forest's age and its fungi.
Roughly 10 percent of all plant species are orchids, making them the largest plant family on Earth. But habitat loss has rendered many threatened or endangered. This is partly due to their intimate relationship with the soil.
Orchids depend entirely on microscopic fungi in the early stages of their lives. Without the ...
